Presentation TCT 2016 Saudi Arabia Presents: A Case of Coronary Compression After TAVR Presenter: Juan F. Granada, Oscar A. Mendiz, Fawaz AlMotairi November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
Presentation TCT 2016 PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen November 01, 2016
Presentation TCT 2016 Saudi Arabia Presents: A Case When TAVR Crashes Presenter: Juan F. Granada, Oscar A. Mendiz, Khaled F Al-Shaibi November 01, 2016
Presentation TCT 2016 Early Feasibility of a Percutaneous Tricuspid Valve Annuloplasty System for Symptomatic Chronic Functional Tricuspid Regurgitation: 30-Day Results From the SCOUT Trial Presenter: Ted Feldman, David Hildick-Smith, Rebecca T. Hahn November 01, 2016
Presentation TCT 2016 One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson November 01, 2016
Presentation TCT 2016 One-Year Outcomes from the Early Feasibility Study of the Harmony Trans-Catheter Pulmonary Valve Presenter: Ted Feldman, David Hildick-Smith, Lee N. Benson November 01, 2016
Presentation TCT 2016 Percutaneous Suture Based PFO Closure with the NobleStitch EL Device: Initial Multicenter Clinical Experience Presenter: Ted Feldman, David Hildick-Smith, Michael J. Mullen November 01, 2016
Presentation TCT 2016 Prospective Single Center FIH Clinical Trial to Evaluate the Safety and Effectiveness of a Septal Occluder with Bioresorbable Framework in Patients with Clinically Significant ASD or PFO Presenter: Ted Feldman, David Hildick-Smith, Kolja Sievert November 01, 2016
Presentation TCT 2016 Complications 5. Bleeding after TAVR: Incidence, Prognostic Importance, Predictors, and Associations Presenter: Neil E. Moat, John G. Webb, Philippe Généreux October 31, 2016
Presentation TCT 2016 Tunnelling Under the Cage, Rather Than Bending the Jail Bars, Enabled Successful Treatment of a Jailed Left Anterior Descending Artery Presenter: Wojtek Wojakowski, Jerrett K Lau October 31, 2016
Presentation TCT 2016 Strategies to Reduce the Frequency of New Pacemakers After TAVR: Imaging, Procedural, and Device-Related Factors Presenter: Neil E. Moat, John G. Webb, Ian T. Meredith October 31, 2016
Presentation TCT 2016 My Most Challenging Case 2016: Severe LV Dysfunction Presenter: Shao-Liang Chen, Ajay J. Kirtane, Manish A. Parikh, Bo Xu, Qi Zhang October 31, 2016
Presentation TCT 2016 3D-Echocardiographic Guiding of a Novel Transcatheter Mitral Valve Replacement Presenter: Wojtek Wojakowski, Florian Deuschl October 31, 2016
Presentation TCT 2016 Complications 4. Conduction Disturbances: Clinical Implications of New LBBB and New Pacemakers After TAVR Presenter: Neil E. Moat, John G. Webb, Marina Urena October 31, 2016
Presentation TCT 2016 Grand Summary: TMVR Outcomes to Date Successes, Failures, and Implications Presenter: Michael J. Mack, Ralph Stephan von Bardeleben October 31, 2016
Presentation TCT 2016 Trial #9 - The Essentials of IN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions Presenter: William A. Gray, Stephan Windecker, John R. Laird Jr. October 31, 2016
Presentation TCT 2016 St. Jude TMVR: Design Development Update Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Anson Cheung October 31, 2016
Presentation TCT 2016 Strokes and TAVR: Is Stroke Frequency Declining? Etiologic Factors Clinical, Anatomic, Technique-related, and Device-specific Presenter: Neil E. Moat, John G. Webb, Samir R. Kapadia October 31, 2016